BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:09:00 PM | Browse: 1027 | Download: 1027
 |
Received |
|
2014-05-29 10:34 |
|
Peer-Review Started |
|
2014-05-29 13:20 |
|
To Make the First Decision |
|
2014-06-18 18:30 |
|
Return for Revision |
|
2014-06-19 14:11 |
|
Revised |
|
2014-07-03 02:23 |
|
Second Decision |
|
2014-11-12 13:43 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-11-19 11:05 |
|
Articles in Press |
|
2014-11-19 11:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-01-16 13:52 |
|
Publish the Manuscript Online |
|
2015-01-20 11:01 |
| ISSN |
2218-6239 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Svetlana V Kyosseva and James F McGinnis |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| NIH NEI |
R21EY018306 |
| NIH NEI |
R01EY18724 |
| NIH NEI |
R01EY022111 |
| National Science Foundation |
CBET-0708172 |
|
| Corresponding Author |
Svetlana V Kyosseva, PhD, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, United States. svkiosseva@uams.edu |
| Key Words |
Nanoceria; Age-related macular degeneration; Inherited retinal degeneration; Oxidative stress; Antioxidant |
| Core Tip |
This review outlines the recent findings that cerium oxide nanoparticles (nanoceria) may represent novel and broad spectrum therapeutic agents to treat retinal diseases including age-related macular degeneration, retinal angiomatous, inherited retinal degeneration, and fight inflammation and pathologies associated with oxidative stress.
|
| Publish Date |
2015-01-20 11:01 |
| Citation |
Kyosseva SV, McGinnis JF. Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases. World J Ophthalmol 2015; 5(1): 23-30 |
| URL |
http://www.wjgnet.com/2218-6239/full/v5/i1/23.htm |
| DOI |
http://dx.doi.org/10.5318/wjo.v5.i1.23 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
